Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] Journal article

Title	Low-dose foscarnet preemptive therapy for cytomegalovirus viremia after haploidentical bone marrow transplantation.
Author(s)	Wang H, Zhu L, Xue M, Liu J, Guo Z
Source	Biol Blood Marrow Transplant 2009 Apr; 15(4):519-20.
Language	eng
Pub Type(s)	Letter Research Support, Non-U.S. Gov't
PubMed ID	19285642

Advertise on this site.